IBDEI1Z5 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31526,1,4,0)
 ;;=4^O36.1110
 ;;^UTILITY(U,$J,358.3,31526,2)
 ;;=^5016893
 ;;^UTILITY(U,$J,358.3,31527,0)
 ;;=O36.1111^^126^1626^38
 ;;^UTILITY(U,$J,358.3,31527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31527,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization,1st tri,fts 1
 ;;^UTILITY(U,$J,358.3,31527,1,4,0)
 ;;=4^O36.1111
 ;;^UTILITY(U,$J,358.3,31527,2)
 ;;=^5016894
 ;;^UTILITY(U,$J,358.3,31528,0)
 ;;=O36.1112^^126^1626^39
 ;;^UTILITY(U,$J,358.3,31528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31528,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization,1st tri,fts 2
 ;;^UTILITY(U,$J,358.3,31528,1,4,0)
 ;;=4^O36.1112
 ;;^UTILITY(U,$J,358.3,31528,2)
 ;;=^5016895
 ;;^UTILITY(U,$J,358.3,31529,0)
 ;;=O36.1113^^126^1626^54
 ;;^UTILITY(U,$J,358.3,31529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31529,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization1st tri,fts 3
 ;;^UTILITY(U,$J,358.3,31529,1,4,0)
 ;;=4^O36.1113
 ;;^UTILITY(U,$J,358.3,31529,2)
 ;;=^5016896
 ;;^UTILITY(U,$J,358.3,31530,0)
 ;;=O36.1114^^126^1626^40
 ;;^UTILITY(U,$J,358.3,31530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31530,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization,1st tri,fts 4
 ;;^UTILITY(U,$J,358.3,31530,1,4,0)
 ;;=4^O36.1114
 ;;^UTILITY(U,$J,358.3,31530,2)
 ;;=^5016897
 ;;^UTILITY(U,$J,358.3,31531,0)
 ;;=O36.1115^^126^1626^41
 ;;^UTILITY(U,$J,358.3,31531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31531,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization,1st tri,fts 5
 ;;^UTILITY(U,$J,358.3,31531,1,4,0)
 ;;=4^O36.1115
 ;;^UTILITY(U,$J,358.3,31531,2)
 ;;=^5016898
 ;;^UTILITY(U,$J,358.3,31532,0)
 ;;=O36.1120^^126^1626^42
 ;;^UTILITY(U,$J,358.3,31532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31532,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization,2nd tri,unsp fts
 ;;^UTILITY(U,$J,358.3,31532,1,4,0)
 ;;=4^O36.1120
 ;;^UTILITY(U,$J,358.3,31532,2)
 ;;=^5016900
 ;;^UTILITY(U,$J,358.3,31533,0)
 ;;=O36.1121^^126^1626^43
 ;;^UTILITY(U,$J,358.3,31533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31533,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization,2nd tri,fts 1
 ;;^UTILITY(U,$J,358.3,31533,1,4,0)
 ;;=4^O36.1121
 ;;^UTILITY(U,$J,358.3,31533,2)
 ;;=^5016901
 ;;^UTILITY(U,$J,358.3,31534,0)
 ;;=O36.1122^^126^1626^44
 ;;^UTILITY(U,$J,358.3,31534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31534,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization,2nd tri,fts 2
 ;;^UTILITY(U,$J,358.3,31534,1,4,0)
 ;;=4^O36.1122
 ;;^UTILITY(U,$J,358.3,31534,2)
 ;;=^5016902
 ;;^UTILITY(U,$J,358.3,31535,0)
 ;;=O36.1123^^126^1626^45
 ;;^UTILITY(U,$J,358.3,31535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31535,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization,2nd tri,fts 3
 ;;^UTILITY(U,$J,358.3,31535,1,4,0)
 ;;=4^O36.1123
 ;;^UTILITY(U,$J,358.3,31535,2)
 ;;=^5016903
 ;;^UTILITY(U,$J,358.3,31536,0)
 ;;=O36.1124^^126^1626^46
 ;;^UTILITY(U,$J,358.3,31536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31536,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization,2nd tri,fts 4
 ;;^UTILITY(U,$J,358.3,31536,1,4,0)
 ;;=4^O36.1124
 ;;^UTILITY(U,$J,358.3,31536,2)
 ;;=^5016904
 ;;^UTILITY(U,$J,358.3,31537,0)
 ;;=O36.1125^^126^1626^47
 ;;^UTILITY(U,$J,358.3,31537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31537,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization,2nd tri,fts 5
 ;;^UTILITY(U,$J,358.3,31537,1,4,0)
 ;;=4^O36.1125
 ;;^UTILITY(U,$J,358.3,31537,2)
 ;;=^5016905
 
--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1Z5   3779     printed  Sep 23, 2025@19:54:39                                                                                                                                                                                                    Page 2
IBDEI1Z5  ; ; 04-FEB-2020
 +1       ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 +2        if 'DIFQR(358.3)
               QUIT 
           FOR I=1:2
               SET X=$TEXT(Q+I)
               if X=""
                   QUIT 
               SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
               SET X=$EXTRACT(X,4,999)
               if $ASCII(Y)=126
                   SET I=I+1
                   SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
               if $ASCII(Y)=61
                   SET Y=$EXTRACT(Y,2,999)
               XECUTE NO
              IF '$TEST
                   SET @X=Y
Q          QUIT 
 +1       ;;^UTILITY(U,$J,358.3,31526,1,4,0)
 +2       ;;=4^O36.1110
 +3       ;;^UTILITY(U,$J,358.3,31526,2)
 +4       ;;=^5016893
 +5       ;;^UTILITY(U,$J,358.3,31527,0)
 +6       ;;=O36.1111^^126^1626^38
 +7       ;;^UTILITY(U,$J,358.3,31527,1,0)
 +8       ;;=^358.31IA^4^2
 +9       ;;^UTILITY(U,$J,358.3,31527,1,3,0)
 +10      ;;=3^Maternal care for Anti-A sensitization,1st tri,fts 1
 +11      ;;^UTILITY(U,$J,358.3,31527,1,4,0)
 +12      ;;=4^O36.1111
 +13      ;;^UTILITY(U,$J,358.3,31527,2)
 +14      ;;=^5016894
 +15      ;;^UTILITY(U,$J,358.3,31528,0)
 +16      ;;=O36.1112^^126^1626^39
 +17      ;;^UTILITY(U,$J,358.3,31528,1,0)
 +18      ;;=^358.31IA^4^2
 +19      ;;^UTILITY(U,$J,358.3,31528,1,3,0)
 +20      ;;=3^Maternal care for Anti-A sensitization,1st tri,fts 2
 +21      ;;^UTILITY(U,$J,358.3,31528,1,4,0)
 +22      ;;=4^O36.1112
 +23      ;;^UTILITY(U,$J,358.3,31528,2)
 +24      ;;=^5016895
 +25      ;;^UTILITY(U,$J,358.3,31529,0)
 +26      ;;=O36.1113^^126^1626^54
 +27      ;;^UTILITY(U,$J,358.3,31529,1,0)
 +28      ;;=^358.31IA^4^2
 +29      ;;^UTILITY(U,$J,358.3,31529,1,3,0)
 +30      ;;=3^Maternal care for Anti-A sensitization1st tri,fts 3
 +31      ;;^UTILITY(U,$J,358.3,31529,1,4,0)
 +32      ;;=4^O36.1113
 +33      ;;^UTILITY(U,$J,358.3,31529,2)
 +34      ;;=^5016896
 +35      ;;^UTILITY(U,$J,358.3,31530,0)
 +36      ;;=O36.1114^^126^1626^40
 +37      ;;^UTILITY(U,$J,358.3,31530,1,0)
 +38      ;;=^358.31IA^4^2
 +39      ;;^UTILITY(U,$J,358.3,31530,1,3,0)
 +40      ;;=3^Maternal care for Anti-A sensitization,1st tri,fts 4
 +41      ;;^UTILITY(U,$J,358.3,31530,1,4,0)
 +42      ;;=4^O36.1114
 +43      ;;^UTILITY(U,$J,358.3,31530,2)
 +44      ;;=^5016897
 +45      ;;^UTILITY(U,$J,358.3,31531,0)
 +46      ;;=O36.1115^^126^1626^41
 +47      ;;^UTILITY(U,$J,358.3,31531,1,0)
 +48      ;;=^358.31IA^4^2
 +49      ;;^UTILITY(U,$J,358.3,31531,1,3,0)
 +50      ;;=3^Maternal care for Anti-A sensitization,1st tri,fts 5
 +51      ;;^UTILITY(U,$J,358.3,31531,1,4,0)
 +52      ;;=4^O36.1115
 +53      ;;^UTILITY(U,$J,358.3,31531,2)
 +54      ;;=^5016898
 +55      ;;^UTILITY(U,$J,358.3,31532,0)
 +56      ;;=O36.1120^^126^1626^42
 +57      ;;^UTILITY(U,$J,358.3,31532,1,0)
 +58      ;;=^358.31IA^4^2
 +59      ;;^UTILITY(U,$J,358.3,31532,1,3,0)
 +60      ;;=3^Maternal care for Anti-A sensitization,2nd tri,unsp fts
 +61      ;;^UTILITY(U,$J,358.3,31532,1,4,0)
 +62      ;;=4^O36.1120
 +63      ;;^UTILITY(U,$J,358.3,31532,2)
 +64      ;;=^5016900
 +65      ;;^UTILITY(U,$J,358.3,31533,0)
 +66      ;;=O36.1121^^126^1626^43
 +67      ;;^UTILITY(U,$J,358.3,31533,1,0)
 +68      ;;=^358.31IA^4^2
 +69      ;;^UTILITY(U,$J,358.3,31533,1,3,0)
 +70      ;;=3^Maternal care for Anti-A sensitization,2nd tri,fts 1
 +71      ;;^UTILITY(U,$J,358.3,31533,1,4,0)
 +72      ;;=4^O36.1121
 +73      ;;^UTILITY(U,$J,358.3,31533,2)
 +74      ;;=^5016901
 +75      ;;^UTILITY(U,$J,358.3,31534,0)
 +76      ;;=O36.1122^^126^1626^44
 +77      ;;^UTILITY(U,$J,358.3,31534,1,0)
 +78      ;;=^358.31IA^4^2
 +79      ;;^UTILITY(U,$J,358.3,31534,1,3,0)
 +80      ;;=3^Maternal care for Anti-A sensitization,2nd tri,fts 2
 +81      ;;^UTILITY(U,$J,358.3,31534,1,4,0)
 +82      ;;=4^O36.1122
 +83      ;;^UTILITY(U,$J,358.3,31534,2)
 +84      ;;=^5016902
 +85      ;;^UTILITY(U,$J,358.3,31535,0)
 +86      ;;=O36.1123^^126^1626^45
 +87      ;;^UTILITY(U,$J,358.3,31535,1,0)
 +88      ;;=^358.31IA^4^2
 +89      ;;^UTILITY(U,$J,358.3,31535,1,3,0)
 +90      ;;=3^Maternal care for Anti-A sensitization,2nd tri,fts 3
 +91      ;;^UTILITY(U,$J,358.3,31535,1,4,0)
 +92      ;;=4^O36.1123
 +93      ;;^UTILITY(U,$J,358.3,31535,2)
 +94      ;;=^5016903
 +95      ;;^UTILITY(U,$J,358.3,31536,0)
 +96      ;;=O36.1124^^126^1626^46
 +97      ;;^UTILITY(U,$J,358.3,31536,1,0)
 +98      ;;=^358.31IA^4^2
 +99      ;;^UTILITY(U,$J,358.3,31536,1,3,0)
 +100     ;;=3^Maternal care for Anti-A sensitization,2nd tri,fts 4
 +101     ;;^UTILITY(U,$J,358.3,31536,1,4,0)
 +102     ;;=4^O36.1124
 +103     ;;^UTILITY(U,$J,358.3,31536,2)
 +104     ;;=^5016904
 +105     ;;^UTILITY(U,$J,358.3,31537,0)
 +106     ;;=O36.1125^^126^1626^47
 +107     ;;^UTILITY(U,$J,358.3,31537,1,0)
 +108     ;;=^358.31IA^4^2
 +109     ;;^UTILITY(U,$J,358.3,31537,1,3,0)
 +110     ;;=3^Maternal care for Anti-A sensitization,2nd tri,fts 5
 +111     ;;^UTILITY(U,$J,358.3,31537,1,4,0)
 +112     ;;=4^O36.1125
 +113     ;;^UTILITY(U,$J,358.3,31537,2)
 +114     ;;=^5016905